Clinical Trial

Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD

Study acronym: DDH-LSD
Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates DDH-LSD, a novel LSD-like compound expected to have a shorter duration of action than LSD. In healthy volunteers, pharmacokinetics, safety, and subjective effects, will be assessed and compare with LSD in a controlled cross-over study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-15; most recent amendment 2026-03-09.
Status change: Not Yet Recruiting → Recruiting 2026-03-03
Trial Details
NCT Number NCT07309471
Lead Sponsor University Hospital, Basel, Switzerland
Conditions LSD Reaction
Enrollment 24 participants
Start Date 2026-03-06
Primary Completion 2028-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-10